Literature DB >> 19176810

The Parkinson disease protein leucine-rich repeat kinase 2 transduces death signals via Fas-associated protein with death domain and caspase-8 in a cellular model of neurodegeneration.

Cherry Cheng-Ying Ho1, Hardy J Rideout, Elena Ribe, Carol M Troy, William T Dauer.   

Abstract

Neurodegenerative illnesses such as Parkinson and Alzheimer disease are an increasingly prevalent problem in aging societies, yet no therapies exist that retard or prevent neurodegeneration. Dominant missense mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common genetic cause of Parkinson disease (PD), but the mechanisms by which mutant forms of LRRK2 disrupt neuronal function and cause cell death remain poorly understood. We report that LRRK2 interacts with the death adaptor Fas-associated protein with death domain (FADD), and that in primary neuronal culture LRRK2-mediated neurodegeneration is prevented by the functional inhibition of FADD or depletion of caspase-8, two key elements of the extrinsic cell death pathway. This pathway is activated by disease-triggering mutations, which enhance the LRRK2-FADD association and the consequent recruitment and activation of caspase-8. These results establish a direct molecular link between a mutant PD gene and the activation of programmed cell death signaling, and suggest that FADD/caspase-8 signaling contributes to LRRK2-induced neuronal death.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19176810      PMCID: PMC2768412          DOI: 10.1523/JNEUROSCI.5175-08.2009

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  38 in total

Review 1.  The protein kinase complement of the human genome.

Authors:  G Manning; D B Whyte; R Martinez; T Hunter; S Sudarsanam
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

Review 2.  Targeting programmed cell death in neurodegenerative diseases.

Authors:  Miquel Vila; Serge Przedborski
Journal:  Nat Rev Neurosci       Date:  2003-05       Impact factor: 34.870

3.  Atypical role of proximal caspase-8 in truncated Tau-induced neurite regression and neuronal cell death.

Authors:  Chul-Woong Chung; Yeon-Mi Hong; Sungmin Song; Ha-Na Woo; Yun-Hee Choi; Troy Rohn; Yong-Keun Jung
Journal:  Neurobiol Dis       Date:  2003-12       Impact factor: 5.996

4.  A unified model for apical caspase activation.

Authors:  Kelly M Boatright; Martin Renatus; Fiona L Scott; Sabina Sperandio; Hwain Shin; Irene M Pedersen; Jean Ehrland Ricci; Wade A Edris; Daniel P Sutherlin; Douglas R Green; Guy S Salvesen
Journal:  Mol Cell       Date:  2003-02       Impact factor: 17.970

5.  In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease.

Authors:  C S Lee; A Samii; V Sossi; T J Ruth; M Schulzer; J E Holden; J Wudel; P K Pal; R de la Fuente-Fernandez; D B Calne; A J Stoessl
Journal:  Ann Neurol       Date:  2000-04       Impact factor: 10.422

Review 6.  Parkinson's disease: mechanisms and models.

Authors:  William Dauer; Serge Przedborski
Journal:  Neuron       Date:  2003-09-11       Impact factor: 17.173

7.  NF-kappa B functions in synaptic signaling and behavior.

Authors:  Mollie K Meffert; Jolene M Chang; Brian J Wiltgen; Michael S Fanselow; David Baltimore
Journal:  Nat Neurosci       Date:  2003-08-31       Impact factor: 24.884

8.  Caspase-3 and caspase-9 mediate developmental apoptosis in the mouse olfactory system.

Authors:  Catherine M Cowan; A Jane Roskams
Journal:  J Comp Neurol       Date:  2004-06-14       Impact factor: 3.215

9.  Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells.

Authors:  Edward D Plowey; Salvatore J Cherra; Yong-Jian Liu; Charleen T Chu
Journal:  J Neurochem       Date:  2008-01-07       Impact factor: 5.372

10.  Regulation of dopaminergic loss by Fas in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.

Authors:  Shawn Hayley; Stephen J Crocker; Patrice D Smith; Tanaya Shree; Vernice Jackson-Lewis; Serge Przedborski; Matthew Mount; Ruth Slack; Hymie Anisman; David S Park
Journal:  J Neurosci       Date:  2004-02-25       Impact factor: 6.167

View more
  72 in total

Review 1.  Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences.

Authors:  Nicole Exner; Anne Kathrin Lutz; Christian Haass; Konstanze F Winklhofer
Journal:  EMBO J       Date:  2012-06-26       Impact factor: 11.598

2.  (G2019S) LRRK2 activates MKK4-JNK pathway and causes degeneration of SN dopaminergic neurons in a transgenic mouse model of PD.

Authors:  C-Y Chen; Y-H Weng; K-Y Chien; K-J Lin; T-H Yeh; Y-P Cheng; C-S Lu; H-L Wang
Journal:  Cell Death Differ       Date:  2012-04-27       Impact factor: 15.828

3.  LRRK2 and the stress response: interaction with MKKs and JNK-interacting proteins.

Authors:  C H Hsu; D Chan; B Wolozin
Journal:  Neurodegener Dis       Date:  2010-02-18       Impact factor: 2.977

4.  Characterization of the Roco protein family in Dictyostelium discoideum.

Authors:  Wouter N van Egmond; Peter J M van Haastert
Journal:  Eukaryot Cell       Date:  2010-03-26

5.  Unexpected lack of hypersensitivity in LRRK2 knock-out mice to MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine).

Authors:  Eva Andres-Mateos; Rebeca Mejias; Masayuki Sasaki; Xiaojie Li; Brian M Lin; Saskia Biskup; Li Zhang; Rebecca Banerjee; Bobby Thomas; Lichuan Yang; Guosheng Liu; M Flint Beal; David L Huso; Ted M Dawson; Valina L Dawson
Journal:  J Neurosci       Date:  2009-12-16       Impact factor: 6.167

Review 6.  Programmed cell death in Parkinson's disease.

Authors:  Katerina Venderova; David S Park
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

7.  Caspase-8 Mediates Amyloid-β-induced Apoptosis in Differentiated PC12 Cells.

Authors:  Min-cai Qian; Jing Liu; Jia-shu Yao; Wei-min Wang; Jian-hong Yang; Li-li Wei; Yue-di Shen; Wei Chen
Journal:  J Mol Neurosci       Date:  2015-02-03       Impact factor: 3.444

8.  GTPase activity plays a key role in the pathobiology of LRRK2.

Authors:  Yulan Xiong; Candice E Coombes; Austin Kilaru; Xiaojie Li; Aaron D Gitler; William J Bowers; Valina L Dawson; Ted M Dawson; Darren J Moore
Journal:  PLoS Genet       Date:  2010-04-08       Impact factor: 5.917

9.  Signal transduction protein array analysis links LRRK2 to Ste20 kinases and PKC zeta that modulate neuronal plasticity.

Authors:  Susanne Zach; Sandra Felk; Frank Gillardon
Journal:  PLoS One       Date:  2010-10-07       Impact factor: 3.240

10.  The WD40 domain is required for LRRK2 neurotoxicity.

Authors:  Nathan D Jorgensen; Yong Peng; Cherry C-Y Ho; Hardy J Rideout; Donald Petrey; Peng Liu; William T Dauer
Journal:  PLoS One       Date:  2009-12-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.